UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$21.6B |
| 2 |
Amazon
AMZN
|
+$13.7B |
| 3 |
NVIDIA
NVDA
|
+$3.87B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.89B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$22.7B |
| 2 |
Equinix
EQIX
|
+$857M |
| 3 |
Digital Realty Trust
DLR
|
+$655M |
| 4 |
NetEase
NTES
|
+$618M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$609M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.9% |
| 2 | Financials | 13.9% |
| 3 | Consumer Discretionary | 11.31% |
| 4 | Healthcare | 10.7% |
| 5 | Communication Services | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
PureCycle Technologies
PCT
$1.45B
| $6.21M | ﹤0.01% |
453,604
+168,744
| +59% | +$1.49M |
|
1602
BioCryst Pharmaceuticals
BCRX
$2.4B
| $6.2M | ﹤0.01% |
691,969
+243,503
| +54% | +$2.27M |
|
1603
DigitalBridge
DBRG
$2.95B
| $6.17M | ﹤0.01% |
596,056
+203,962
| +52% | +$1.95M |
|
1604
First Busey Corp
BUSE
$2.56B
| $6.15M | ﹤0.01% |
268,947
+46,899
| +21% | +$1.02M |
|
1605
Sabra Healthcare REIT
SBRA
$5.37B
| $6.15M | ﹤0.01% |
333,532
-1,354,445
| -80% | -$24M |
|
1606
Materion
MTRN
$6.04B
| $6.14M | ﹤0.01% |
77,419
+23,374
| +43% | +$1.84M |
|
1607
RXO
RXO
$3.58B
| $6.14M | ﹤0.01% |
390,589
+107,216
| +38% | +$1.63M |
|
1608
Kinetik
KNTK
$7.98B
| $6.14M | ﹤0.01% |
139,352
+59,820
| +75% | +$2.63M |
|
1609
Greif
GEF
$5.04B
| $6.14M | ﹤0.01% |
94,411
+26,533
| +39% | +$1.51M |
|
1610
American Healthcare REIT
AHR
$10.9B
| $6.13M | ﹤0.01% |
166,953
-761,922
| -82% | -$25.3M |
|
|
EMA
1611
Emera Inc
EMA
$15.6B
| $6.12M | ﹤0.01% |
+133,644
| New | +$6M |
|
1612
Comstock Resources
CRK
$3.94B
| $6.12M | ﹤0.01% |
221,042
+83,024
| +60% | +$1.89M |
|
|
CON
1613
Concentra Group Holdings
CON
$4.36B
| $6.12M | ﹤0.01% |
297,297
+86,771
| +41% | +$1.85M |
|
1614
HDFC Bank
HDB
$121B
| $6.11M | ﹤0.01% |
159,422
-8,240,012
| -98% | -$299M |
|
1615
United Parks & Resorts
PRKS
$2.12B
| $6.1M | ﹤0.01% |
129,414
+27,097
| +26% | +$1.21M |
|
1616
Otter Tail
OTTR
$3.94B
| $6.07M | ﹤0.01% |
78,778
+33,136
| +73% | +$2.59M |
|
1617
Schneider National
SNDR
$6.25B
| $6.05M | ﹤0.01% |
250,421
+71,988
| +40% | +$1.67M |
|
|
BBT
1618
Beacon Financial Corp
BBT
$2.66B
| $6.02M | ﹤0.01% |
240,521
+97,827
| +69% | +$2.43M |
|
1619
Zillow
ZG
$7.63B
| $6.02M | ﹤0.01% |
87,915
+3
| +0% | +$199 |
|
|
VISN
1620
Vistance Networks Inc
VISN
$2.52B
| $6.02M | ﹤0.01% |
726,588
+205,911
| +40% | +$1.08M |
|
1621
International Seaways
INSW
$4.57B
| $5.99M | ﹤0.01% |
164,152
+35,724
| +28% | +$1.28M |
|
1622
Intellia Therapeutics
NTLA
$1.67B
| $5.98M | ﹤0.01% |
637,861
+116,155
| +22% | +$954K |
|
1623
Nelnet
NNI
$4.7B
| $5.96M | ﹤0.01% |
49,197
-9,218
| -16% | -$1.03M |
|
1624
Spectrum Brands
SPB
$2.07B
| $5.96M | ﹤0.01% |
112,424
+853
| +0.8% | +$50.9K |
|
1625
Healthcare Realty
HR
$6.84B
| $5.96M | ﹤0.01% |
375,691
-1,834,249
| -83% | -$27.9M |
|
Similar funds
UBS AM's Q2 2025 Portfolio in Review
As of Q2 2025, UBS AM held 2,749 positions worth $494B, up 26% from $391B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
UBS AM deployed $54.3B of net new capital in Q2 2025, opening 106 new positions and adding to 2,036 existing holdings. Its largest new stake was Amrize Ltd: 12,343,881 shares worth $612M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Microsoft, an estimated $22.7B trimmed.
- UBS AM's largest Q2 2025 buy was Amrize Ltd: 12,343,881 shares worth $612M.
- UBS AM added most to Apple in Q2 2025, an estimated $21.6B increase.
- UBS AM's biggest Q2 2025 reduction was Microsoft, cutting an estimated $22.7B.
- UBS AM fully exited Discover Financial Services in Q2 2025, selling an estimated $356M.
- UBS AM's ten largest holdings make up 28% of its $494B portfolio in Q2 2025.
- UBS AM opened 106 new positions and closed 128 in Q2 2025.
- UBS AM's portfolio value rose 26% quarter-over-quarter to $494B.
Based on UBS AM's 13F filing for Q2 2025, filed 14 Aug 2025.